Filing Details

Accession Number:
0001209191-16-127845
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-06-14 18:45:11
Reporting Period:
2016-06-13
Filing Date:
2016-06-14
Accepted Time:
2016-06-14 18:45:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1305253 Eiger Biopharmaceuticals Inc. EIGR Biological Products, (No Disgnostic Substances) (2836) 361004130
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1488919 P James Shaffer 350 Cambridge Ave, Suite 350
Palo Alto CA 94306
Chief Business Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-06-13 730 $22.16 1,975 No 4 P Direct
Common Stock Acquisiton 2016-06-13 100 $22.17 2,075 No 4 P Direct
Common Stock Acquisiton 2016-06-13 420 $22.20 2,495 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct